NABP report lumps real and rogue pharmacies together
Rogue websites that sell fake and counterfeit prescription drugs are a problem. They jeopardize public health and give legitimate sites providing Americans with authentic, affordable medicines a bad rep. It is in everyone’s interest to eliminate these phonies.
But the recent National Association of Boards of Pharmacy (NABP) report on Internet pharmacies once again goes too far. It lumps rogue and real pharmacies together, barring all non-U.S. pharmacies from their “safe” designation.
The report isn’t surprising; NABP has a habit of demonizing all international online pharmacies. The pharmaceutical industry has an obvious motive for suppressing importation. And though NABP claims to be an “independent, international, and impartial Association,” their VIPPS program for identifying “safe” online pharmacies was initially launched by a Pfizer grant.
You might also recall that NABP is leading the charge for a designated .pharmacy domain for the industry. It is important to note that Big Pharma is footing the bill for this endeavor. Eli Lilly and Merck are the top contributors, they have each given $100,000 or more to help secure .pharmacy.
Thanks to those of you who have signed our petition opposing a .pharmacy domain controlled by NABP. Due to NABP’s current stance towards even legitimate non-U.S. pharmacies, we are convinced that it would jeopardize the lifeline to safe and affordable medicine from Canadian and overseas that so many Americans depend on.
The public should have input in this major decision regarding the freedom to purchase cheaper prescription drugs online. We’ll soon be sharing your signatures with the Internet Corporation for Assigned Names and Numbers (ICANN)—the global group in charge of reviewing and approving new domains. Stay tuned for updates.